Kongtawelert et al. summarized that sesamin (200 μM) suppressed PD-L1 expression through AKT, NF, and JAK/STAT signaling inhibition in MDA-MB 231 breast cancer cell lines [69]. This evidence concerns the gene AKT1 and breast carcinoma.